← Leaderboards
Alan David D'andrea
Dana-Farber Cancer Inst
$28,094,196
Attributed
$30,678,661
Total exposure
22
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$62,380,546 · 25
By mechanism
P50$16,037,664 · 8
P01$14,300,624 · 5
U19$12,334,739 · 5
R01$11,229,690 · 3
R37$3,945,083 · 1
RC4$3,876,697 · 1
Top collaborators
- Ursula Anne Matulonis5 shared
- Cesar M Castro3 shared
- David R Spriggs2 shared
- George Q Daley1 shared
- David A Williams1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Joyce Liu$1,990,890
- Cheuk-Ting Law$109,448
Others in their field
Top investigators on “Dna Repair”
- John A Tainer · Scripps Research Institute$45,990,082
- Aziz Sancar · University Of North Carolina Chapel Hill$30,640,499
- Patrick Sung · University Of Texas Hlth Sci Ctr San Ant$30,442,761
- John M Essigmann · Massachusetts Institute Of Technology$27,654,594
- Loic Le Marchand · University Of Hawaii At Manoa$26,643,180
- Maria Jasin · Sloan-Kettering Institute For Cancer Res$25,953,946
Research focus
Dna RepairGrantMalignant NeoplasmsPathway InteractionsLaboratoriesCellsCollaborationsFanconi&AposS AnemiaProteinsGenesMutationDna DamageIn VivoMouse ModelFanconi Anemia-Brca PathwayComplexResearch PersonnelProgramsHypersensitivityMediatingPredispositionDna Crosslinking AgentDna Repair Pathway
Grant awards (111)
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma$523,292
R01 · FY2025 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$445,000
R01 · FY2025 · HL · contact PI
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$2,309,363
P50 · FY2024 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$445,000
R01 · FY2024 · HL · contact PI
Organoid, Mouse Model, and Biomarker$242,363
P50 · FY2024 · CA · contact PI
Core A: Administrative Core$156,095
P50 · FY2024 · CA · contact PI
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$2,245,572
P50 · FY2023 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$430,696
R01 · FY2023 · HL · contact PI
Organoid, Mouse Model, and Biomarker$196,772
P50 · FY2023 · CA · contact PI
Core A: Administrative Core$147,655
P50 · FY2023 · CA · contact PI
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$2,156,021
P50 · FY2022 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$431,033
R01 · FY2022 · HL · contact PI
Organoid, Mouse Model, and Biomarker$236,694
P50 · FY2022 · CA · contact PI
Core A: Administrative Core$177,554
P50 · FY2022 · CA · contact PI
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$2,264,107
P50 · FY2021 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$431,370
R01 · FY2021 · HL · contact PI
Organoid, Mouse Model, and Biomarker$198,832
P50 · FY2021 · CA · contact PI
Core A: Administrative Core$149,714
P50 · FY2021 · CA · contact PI
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant$2,483,069
P50 · FY2020 · CA · contact PI
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells$433,367
P01 · FY2020 · HL · contact PI
Molecular Pathogenesis of Fanconi Anemia$431,708
R01 · FY2020 · HL · contact PI
Organoid, Mouse Model, and Biomarker$258,995
P50 · FY2020 · CA · contact PI
Core A: Administrative Core$172,059
P50 · FY2020 · CA · contact PI
Developmental Research Program$162,580
P50 · FY2020 · CA · contact PI
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells$433,447
P01 · FY2019 · HL · contact PI
Developmental Research Program$275,841
P50 · FY2019 · CA · contact PI
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells$433,524
P01 · FY2018 · HL · contact PI
Molecular Pathogenesis of Fanconi Anemia$400,792
R01 · FY2018 · HL · contact PI
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells$433,726
P01 · FY2017 · HL · contact PI
Molecular Pathogenesis of Fanconi Anemia$400,792
R01 · FY2017 · HL · contact PI
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance$219,162
P50 · FY2017 · CA · contact PI
TGF beta Pathway Inhibitors Rescue the Growth of Fanconi Anemia Primary Cells$446,576
P01 · FY2016 · HL · contact PI
Molecular Pathogenesis of Fanconi Anemia$400,792
R01 · FY2016 · HL · contact PI
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance$232,151
P50 · FY2016 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$400,792
R01 · FY2015 · HL · contact PI
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance$271,478
P50 · FY2015 · CA · contact PI
Mechanism of Bone Marrow Failure in Fanconi Anemia$126,865
R56 · FY2015 · DK · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$503,785
R01 · FY2014 · DK · contact PI
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance$319,454
P50 · FY2014 · CA · contact PI
Small molecule Activators of the Faconi Anemia$278,815
P01 · FY2014 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$495,880
R01 · FY2013 · DK · contact PI
Molecular Pathogenesis of Fanconi Anemia$393,499
R37 · FY2013 · HL · contact PI
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance$309,407
P50 · FY2013 · CA · contact PI
Small molecule Activators of the Faconi Anemia$262,630
P01 · FY2013 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$524,141
R01 · FY2012 · DK · contact PI
Molecular Pathogenesis of Fanconi Anemia$413,340
R37 · FY2012 · HL · contact PI
Small molecule Activators of the Faconi Anemia$296,681
P01 · FY2012 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$603,012
R01 · FY2011 · DK · contact PI
Molecular Pathogenesis of Fanconi Anemia$417,515
R37 · FY2011 · HL · contact PI
Small molecule Activators of the Faconi Anemia$301,653
P01 · FY2011 · HL · contact PI
Novel therapies for Fanconi anemia$3,876,697
RC4 · FY2010 · DK
Molecular Pathogenesis of Fanconi Anemia$430,338
R37 · FY2010 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$330,239
R01 · FY2010 · DK · contact PI
Small molecule Activators of the Faconi Anemia$187,901
P01 · FY2010 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$100,290
R01 · FY2010 · DK · contact PI
Centers for Medical Countermeasures Against Radiation$1,860,332
U19 · FY2009 · AI · contact PI
Radiation Biology Training Program$529,184
T32 · FY2009 · CA · contact PI
Molecular Pathogenesis of Fanconi Anemia$390,556
R37 · FY2009 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$333,575
R01 · FY2009 · DK · contact PI
Cell-based, small molecule screens for novel radioprotective agents$192,468
U19 · FY2009 · AI · contact PI
Centers for Medical Countermeasures Against Radiation$126,814
U19 · FY2009 · AI · contact PI
Core--Education$102,178
U19 · FY2009 · AI · contact PI
Core--Pilot grant program$83,352
U19 · FY2009 · AI · contact PI
Centers for Medical Countermeasures Against Radiation$1,860,332
U19 · FY2008 · AI · contact PI
Molecular Pathogenesis of Fanconi Anemia$364,813
R37 · FY2008 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$333,575
R01 · FY2008 · DK · contact PI
Cell-based, small molecule screens for novel radioprotective agents$192,468
U19 · FY2008 · AI · contact PI
Core--Education$102,172
U19 · FY2008 · AI · contact PI
Core--Pilot grant program$83,345
U19 · FY2008 · AI · contact PI
Centers for Medical Countermeasures Against Radiation$2,096,360
U19 · FY2007 · AI · contact PI
Molecular Pathogenesis of Fanconi Anemia$364,813
R37 · FY2007 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$340,384
R01 · FY2007 · DK · contact PI
Cell-based, small molecule screens for novel radioprotective agents$242,979
U19 · FY2007 · AI · contact PI
Core--Education$173,373
U19 · FY2007 · AI · contact PI
Core--Pilot grant program$158,858
U19 · FY2007 · AI · contact PI
Centers for Medical Countermeasures Against Radiation$1,953,000
U19 · FY2006 · AI · contact PI
Abnormalities/Signal Transduction/Hematopoietic Disease$1,703,301
P01 · FY2006 · DK · contact PI
Molecular Pathogenesis of Fanconi Anemia$375,709
R37 · FY2006 · HL · contact PI
Regulation of the Fanconi Anemia Pathway by Ubiquitination$349,696
R01 · FY2006 · DK · contact PI
Cell-based, small molecule screens for novel radioprotective agents$211,452
U19 · FY2006 · AI · contact PI
Core--Education$145,379
U19 · FY2006 · AI · contact PI
Core--Pilot grant program$131,263
U19 · FY2006 · AI · contact PI
Centers for Medical Countermeasures Against Radiation$1,999,999
U19 · FY2005 · AI
Abnormalities/Signal Transduction/Hematopoietic Disease$1,700,337
P01 · FY2005 · DK
Molecular Pathogenesis of Fanconi Anemia$384,750
R37 · FY2005 · HL
Hematopoiesis by Ubiquitination and Deubiquitination$265,052
R01 · FY2005 · DK
Cell-based, small molecule screens for novel radioprotective agents$218,266
U19 · FY2005 · AI
Core--Education$144,678
U19 · FY2005 · AI
Core--Pilot grant program$130,562
U19 · FY2005 · AI
Administrative$125,109
U19 · FY2005 · AI
Abnormalities/Signal Transduction/Hematopoietic Disease$1,657,653
P01 · FY2004 · DK
Molecular Pathogenesis of Fanconi Anemia$409,750
R37 · FY2004 · HL
Hematopoiesis by Ubiquitination and Deubiquitination$265,052
R01 · FY2004 · DK
Abnormalities/Signal Transduction/Hematopoietic Disease$1,615,281
P01 · FY2003 · DK
MOLECULAR PATHOGENESIS OF FANCONI ANEMIA$315,958
R01 · FY2003 · HL
Hematopoiesis by Ubiquitination and Deubiquitination$265,052
R01 · FY2003 · DK
Abnormalities/Signal Transduction/Hematopoietic Disease$6,592
P01 · FY2003 · DK
Abnormalities/Signal Transduction/Hematopoietic Disease$1,603,814
P01 · FY2002 · DK
Hematopoiesis by Ubiquitination and Deubiquitination$327,088
R01 · FY2002 · DK
MOLECULAR PATHOGENESIS OF FANCONI ANEMIA$308,634
R01 · FY2002 · HL
FANCONI ANEMIA$284,242
P50 · FY2002 · HL
SIGNAL TRANSDUCTION IN THE FANCONI ANEMIA PATHWAY$0
P01 · FY2002 · DK
ABNORMAL SIGNAL TRANSDUCTION IN HEMATOPOIETIC DISEASE$1,045,190
P01 · FY2001 · DK
MOLECULAR PATHOGENESIS OF FANCONI ANEMIA$301,520
R01 · FY2001 · HL
ABNORMALITIES OF THE JAK/STAT PATHWAY IN HEMATOPOIETIC DISEASE$296,752
P01 · FY2001 · DK
FANCONI ANEMIA$284,242
P50 · FY2001 · HL
ABNORMAL SIGNAL TRANSDUCTION IN HEMATOPOIETIC DISEASE$1,014,748
P01 · FY2000 · DK
MOLECULAR PATHOGENESIS OF FANCONI ANEMIA$294,613
R01 · FY2000 · HL
FANCONI ANEMIA$284,242
P50 · FY2000 · HL
HEMATOPOIETIC CELL GROWTH AND DEUBIQUITINATING ENZYMES$230,877
R01 · FY2000 · DK
ABNORMALITIES OF THE JAK/STAT PATHWAY IN HEMATOPOIETIC DISEASE$148,636
P01 · FY2000 · DK